12:00 AM
Jun 26, 2000
 |  BC Week In Review  |  Company News  |  Deals

Atrix, Elan deal

The companies will form a joint venture to develop and commercialize oncology and pain management products using ATRX's BEMA bioerodible...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >